AKT1 and breast carcinoma: Hence, the data indicates that Eupafolin inhibits growth and development of breast cancer cells by modulating the PI3K/Akt, MAPKs and NF-κB signaling pathway, which can be partially mediated by downregulated Cav-1 expression.